−14.30USD
−8.85 MUSD
644.00 KUSD
846.29 K
About Helius Medical Technologies, Inc.
Sector
Industry
CEO
Dane Carl Andreeff
Website
Headquarters
Newtown
Employees (FY)
22
Founded
2014
ISIN
US42328V8019
FIGI
BBG006QSQYY6
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HSDT is 5.18 USD — it has decreased by 2.63% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Helius Medical Technologies, Inc. stocks are traded under the ticker HSDT.
Helius Medical Technologies, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
HSDT stock is 3.50% volatile and has beta coefficient of 2.37. Check out the list of the most volatile stocks — is Helius Medical Technologies, Inc. there?
One year price forecast for Helius Medical Technologies, Inc. has a max estimate of 24.00 USD and a min estimate of 15.00 USD.
HSDT earnings for the last quarter are −5.49 USD whereas the estimation was −6.00 USD which accounts for 8.50% surprise. Estimated earnings for the next quarter are −3.77 USD. See more details about Helius Medical Technologies, Inc. earnings.
Helius Medical Technologies, Inc. revenue for the last quarter amounts to 143.00 K USD despite the estimated figure of 345.00 K USD. In the next quarter revenue is expected to reach 249.67 K USD.
Yes, you can track Helius Medical Technologies, Inc. financials in yearly and quarterly reports right on TradingView.
HSDT stock has fallen by 13.67% compared to the previous week, the month change is a 11.60% fall, over the last year Helius Medical Technologies, Inc. has showed a 52.26% decrease.
HSDT net income for the last quarter is −1.04 M USD, while the quarter before that showed −3.66 M USD of net income which accounts for 71.47% change. Track more Helius Medical Technologies, Inc. financial stats to get the full picture.
Today Helius Medical Technologies, Inc. has the market capitalization of 4.60 M, it has increased by 7.95% over the last week.
No, HSDT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HSDT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Helius Medical Technologies, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 22.00 employees. See our rating of the largest employees — is Helius Medical Technologies, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Helius Medical Technologies, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Helius Medical Technologies, Inc. stock shows the sell signal. See more of Helius Medical Technologies, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Helius Medical Technologies, Inc. future price: according to them, HSDT price has a max estimate of 24.00 USD and a min estimate of 15.00 USD. Read a more detailed Helius Medical Technologies, Inc. forecast: see what analysts think of Helius Medical Technologies, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Helius Medical Technologies, Inc. EBITDA is −12.07 M USD, and current EBITDA margin is −1.88 K%. See more stats in Helius Medical Technologies, Inc. financial statements.